Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMNP

Immune Pharmaceuticals (IMNP) Stock Price, News & Analysis

Immune Pharmaceuticals logo

About Immune Pharmaceuticals Stock (NASDAQ:IMNP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
12.29 million shs
Market Capitalization
$8.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMNP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immune Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

IMNP Stock News Headlines

Best Immunity Supplements for 2024
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
See More Headlines

IMNP Stock Analysis - Frequently Asked Questions

Immune Pharmaceuticals Inc (NASDAQ:IMNP) released its quarterly earnings data on Tuesday, May, 15th. The biopharmaceutical company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.05.

Based on aggregate information from My MarketBeat watchlists, some other companies that Immune Pharmaceuticals investors own include Neovasc (NVCN), LadRx (CYTR), Biopharmx (BPMX), Synergy Pharmaceuticals (SGYP), Gevo (GEVO), Sorrento Therapeutics (SRNE) and Novavax (NVAX).

Company Calendar

Last Earnings
5/15/2018
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:IMNP
Previous Symbol
OTCMKTS:EPCT
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$8.14 million
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:IMNP) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners